APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous (IV) Iron Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intravenous (IV) Iron Drugs Industry Growth and Trends Forecast to 2032

26 December 202599 pages

Choose your research edition.

Industry ResearchIntravenous (IV) Iron Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous (IV) Iron Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Intravenous (IV) Iron Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous (IV) Iron Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous (IV) Iron Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Intravenous (IV) Iron Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intravenous (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intravenous (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous (IV) Iron Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous (IV) Iron Drugs include Takeda Pharmaceutical, Sanofi US, Pharmacosmos, Luitpold Pharmaceuticals, Dalichi Sankyo, AMAG Pharmaceuticals and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intravenous (IV) Iron Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous (IV) Iron Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous (IV) Iron Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous (IV) Iron Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous (IV) Iron Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous (IV) Iron Drugs Market by Company

Takeda Pharmaceutical

Sanofi US

Pharmacosmos

Luitpold Pharmaceuticals

Dalichi Sankyo

AMAG Pharmaceuticals

Allergan

Intravenous (IV) Iron Drugs Segment by Type

Ferric Carboxymaltose

Iron Dextran

Iron Sucrose

Others

Intravenous (IV) Iron Drugs Segment by Application

Gynecology & Obstetrics

Nephrology

Gastroenterology

Cardiology

Oncology

Others

Intravenous (IV) Iron Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous (IV) Iron Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous (IV) Iron Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous (IV) Iron Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous (IV) Iron Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous (IV) Iron Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ferric Carboxymaltose Table 2. Major Company of Iron Dextran Table 3. Major Company of Iron Sucrose Table 4. Major Company of Others Table 5. Global Intravenous (IV) Iron Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Intravenous (IV) Iron Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Intravenous (IV) Iron Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Intravenous (IV) Iron Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Intravenous (IV) Iron Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Intravenous (IV) Iron Drugs Industry Trends Table 27. Intravenous (IV) Iron Drugs Industry Drivers Table 28. Intravenous (IV) Iron Drugs Industry Opportunities and Challenges Table 29. Intravenous (IV) Iron Drugs Industry Restraints Table 30. Global Intravenous (IV) Iron Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Intravenous (IV) Iron Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Intravenous (IV) Iron Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Intravenous (IV) Iron Drugs Sales Share by Company (2021-2026) Table 34. Global Intravenous (IV) Iron Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Intravenous (IV) Iron Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Intravenous (IV) Iron Drugs Major Company Production Sites and Headquarters Table 37. Global Intravenous (IV) Iron Drugs Company, Product Type & Application Table 38. Global Intravenous (IV) Iron Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Intravenous (IV) Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Intravenous (IV) Iron Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Intravenous (IV) Iron Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Intravenous (IV) Iron Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Intravenous (IV) Iron Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Intravenous (IV) Iron Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Intravenous (IV) Iron Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Intravenous (IV) Iron Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Intravenous (IV) Iron Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Intravenous (IV) Iron Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Intravenous (IV) Iron Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Intravenous (IV) Iron Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Intravenous (IV) Iron Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Pharmaceutical Company Information Table 74. Takeda Pharmaceutical Business Overview Table 75. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolio Table 77. Takeda Pharmaceutical Recent Development Table 78. Sanofi US Company Information Table 79. Sanofi US Business Overview Table 80. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sanofi US Intravenous (IV) Iron Drugs Product Portfolio Table 82. Sanofi US Recent Development Table 83. Pharmacosmos Company Information Table 84. Pharmacosmos Business Overview Table 85. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolio Table 87. Pharmacosmos Recent Development Table 88. Luitpold Pharmaceuticals Company Information Table 89. Luitpold Pharmaceuticals Business Overview Table 90. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolio Table 92. Luitpold Pharmaceuticals Recent Development Table 93. Dalichi Sankyo Company Information Table 94. Dalichi Sankyo Business Overview Table 95. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolio Table 97. Dalichi Sankyo Recent Development Table 98. AMAG Pharmaceuticals Company Information Table 99. AMAG Pharmaceuticals Business Overview Table 100. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolio Table 102. AMAG Pharmaceuticals Recent Development Table 103. Allergan Company Information Table 104. Allergan Business Overview Table 105. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Allergan Intravenous (IV) Iron Drugs Product Portfolio Table 107. Allergan Recent Development Table 108. North America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 110. North America Intravenous (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 111. North America Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America Intravenous (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 113. North America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Intravenous (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Intravenous (IV) Iron Drugs Market Share by Country (2021-2026) Table 116. North America Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Intravenous (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 118. Europe Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 120. Europe Intravenous (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 121. Europe Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe Intravenous (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Intravenous (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Intravenous (IV) Iron Drugs Market Share by Country (2021-2026) Table 126. Europe Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Intravenous (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Intravenous (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Intravenous (IV) Iron Drugs Market Share by Country (2021-2026) Table 136. Asia-Pacific Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Intravenous (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 138. Latin America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 140. Latin America Intravenous (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 141. Latin America Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America Intravenous (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Intravenous (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Intravenous (IV) Iron Drugs Market Share by Country (2021-2026) Table 146. Latin America Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Intravenous (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Intravenous (IV) Iron Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Intravenous (IV) Iron Drugs Market Share by Country (2021-2026) Table 156. Middle East and Africa Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Intravenous (IV) Iron Drugs Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Intravenous (IV) Iron Drugs Distributors List Table 161. Intravenous (IV) Iron Drugs Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Intravenous (IV) Iron Drugs Image Figure 2. Global Intravenous (IV) Iron Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous (IV) Iron Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous (IV) Iron Drugs Sales (2021-2032) & (K Units) Figure 5. Ferric Carboxymaltose Image Figure 6. Global Ferric Carboxymaltose Sales YoY Growth (2021-2032) & (K Units) Figure 7. Iron Dextran Image Figure 8. Global Iron Dextran Sales YoY Growth (2021-2032) & (K Units) Figure 9. Iron Sucrose Image Figure 10. Global Iron Sucrose Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Intravenous (IV) Iron Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Intravenous (IV) Iron Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Intravenous (IV) Iron Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Gynecology & Obstetrics Image Figure 28. Global Gynecology & Obstetrics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Nephrology Image Figure 30. Global Nephrology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Gastroenterology Image Figure 32. Global Gastroenterology Sales YoY Growth (2021-2032) & (K Units) Figure 33. Cardiology Image Figure 34. Global Cardiology Sales YoY Growth (2021-2032) & (K Units) Figure 35. Oncology Image Figure 36. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Intravenous (IV) Iron Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Intravenous (IV) Iron Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Intravenous (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Intravenous (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Intravenous (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Intravenous (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Intravenous (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Intravenous (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Intravenous (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Intravenous (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Intravenous (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Intravenous (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Intravenous (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Intravenous (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Intravenous (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Intravenous (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Intravenous (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Intravenous (IV) Iron Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Intravenous (IV) Iron Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Intravenous (IV) Iron Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Intravenous (IV) Iron Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Intravenous (IV) Iron Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Ferric Carboxymaltose
  • Iron Dextran
  • Iron Sucrose
  • Others
Applications
  • Gynecology & Obstetrics
  • Nephrology
  • Gastroenterology
  • Cardiology
  • Oncology
  • Others
Companies covered
  • Takeda Pharmaceutical
  • Sanofi US
  • Pharmacosmos
  • Luitpold Pharmaceuticals
  • Dalichi Sankyo
  • AMAG Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous (IV) Iron Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous (IV) Iron Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous (IV) Iron Drugs Market by Type
  6. 1.3.1 Ferric Carboxymaltose
  7. 1.3.2 Iron Dextran
  8. 1.3.3 Iron Sucrose
  9. 1.3.4 Others
  10. 1.4 Global Intravenous (IV) Iron Drugs Market Size by Type
  11. 1.4.1 Global Intravenous (IV) Iron Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Intravenous (IV) Iron Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Intravenous (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Intravenous (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Intravenous (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Intravenous (IV) Iron Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous (IV) Iron Drugs Industry Trends
  2. 2.2 Intravenous (IV) Iron Drugs Industry Drivers
  3. 2.3 Intravenous (IV) Iron Drugs Industry Opportunities and Challenges
  4. 2.4 Intravenous (IV) Iron Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous (IV) Iron Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous (IV) Iron Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous (IV) Iron Drugs Price (2021-2026)
  4. 3.4 Global Intravenous (IV) Iron Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous (IV) Iron Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous (IV) Iron Drugs Company, Product Type & Application
  7. 3.7 Global Intravenous (IV) Iron Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous (IV) Iron Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous (IV) Iron Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous (IV) Iron Drugs Tier 1, Tier 2, and Tier 3
4 Intravenous (IV) Iron Drugs Regional Status and Outlook
  1. 4.1 Global Intravenous (IV) Iron Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous (IV) Iron Drugs Historic Market Size by Region
  3. 4.2.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous (IV) Iron Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous (IV) Iron Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous (IV) Iron Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous (IV) Iron Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous (IV) Iron Drugs by Application
  1. 5.1 Intravenous (IV) Iron Drugs Market by Application
  2. 5.1.1 Gynecology & Obstetrics
  3. 5.1.2 Nephrology
  4. 5.1.3 Gastroenterology
  5. 5.1.4 Cardiology
  6. 5.1.5 Oncology
  7. 5.1.6 Others
  8. 5.2 Global Intravenous (IV) Iron Drugs Market Size by Application
  9. 5.2.1 Global Intravenous (IV) Iron Drugs Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Intravenous (IV) Iron Drugs Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Intravenous (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Intravenous (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Intravenous (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Intravenous (IV) Iron Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Sanofi US
  8. 6.2.1 Sanofi US Company Information
  9. 6.2.2 Sanofi US Business Overview
  10. 6.2.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi US Intravenous (IV) Iron Drugs Product Portfolio
  12. 6.2.5 Sanofi US Recent Developments
  13. 6.3 Pharmacosmos
  14. 6.3.1 Pharmacosmos Company Information
  15. 6.3.2 Pharmacosmos Business Overview
  16. 6.3.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pharmacosmos Intravenous (IV) Iron Drugs Product Portfolio
  18. 6.3.5 Pharmacosmos Recent Developments
  19. 6.4 Luitpold Pharmaceuticals
  20. 6.4.1 Luitpold Pharmaceuticals Company Information
  21. 6.4.2 Luitpold Pharmaceuticals Business Overview
  22. 6.4.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolio
  24. 6.4.5 Luitpold Pharmaceuticals Recent Developments
  25. 6.5 Dalichi Sankyo
  26. 6.5.1 Dalichi Sankyo Company Information
  27. 6.5.2 Dalichi Sankyo Business Overview
  28. 6.5.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Portfolio
  30. 6.5.5 Dalichi Sankyo Recent Developments
  31. 6.6 AMAG Pharmaceuticals
  32. 6.6.1 AMAG Pharmaceuticals Company Information
  33. 6.6.2 AMAG Pharmaceuticals Business Overview
  34. 6.6.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Portfolio
  36. 6.6.5 AMAG Pharmaceuticals Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Intravenous (IV) Iron Drugs Product Portfolio
  42. 6.7.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous (IV) Iron Drugs Sales by Country
  2. 7.1.1 North America Intravenous (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous (IV) Iron Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous (IV) Iron Drugs Market Size by Country
  6. 7.2.1 North America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous (IV) Iron Drugs Sales by Country
  2. 8.1.1 Europe Intravenous (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous (IV) Iron Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous (IV) Iron Drugs Market Size by Country
  6. 8.2.1 Europe Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous (IV) Iron Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous (IV) Iron Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous (IV) Iron Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous (IV) Iron Drugs Sales by Country
  2. 10.1.1 South America Intravenous (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous (IV) Iron Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous (IV) Iron Drugs Market Size by Country
  6. 10.2.1 South America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous (IV) Iron Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous (IV) Iron Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous (IV) Iron Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous (IV) Iron Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous (IV) Iron Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous (IV) Iron Drugs Value Chain Analysis
  2. 12.1.1 Intravenous (IV) Iron Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous (IV) Iron Drugs Production Mode & Process
  7. 12.2 Intravenous (IV) Iron Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous (IV) Iron Drugs Distributors
  10. 12.2.3 Intravenous (IV) Iron Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst